Drug Shortage Report for ACT-HIB

Last updated on 2020-05-13 History
Report ID 107680
Drug Identification Number 01959034
Brand name ACT-HIB
Common or Proper name Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP
Strength(s) 30MCG 10MCG
Dosage form(s) KIT POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials
ATC code J07AG
ATC description BACTERIAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-03-03
Actual start date 2020-03-03
Estimated end date 2020-06-15
Actual end date 2020-05-12
Shortage status Resolved
Updated date 2020-05-13
Company comments Shortage due to delays in manufacturing and shipment of product for Canada. Allocation plan in place to meet public market demand. Product not available for private market. Resolved on Wednesday May 13, 2020.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-05-13 English Compare
v5 2020-03-04 French Compare
v4 2020-03-04 English Compare
v3 2020-03-04 French Compare
v2 2020-03-04 French Compare
v1 2020-03-04 English Compare